Leverage powerful analytics and robust data
CMM enables the analysis of eligibility, medical claims and prescription claims data for a large national insurer so that manufacturers can better inform strategic product decisions, support data reconciliation and complement existing data.
Users can create highly customized reports and define rules to ensure new patients, discontinuation, switching, concomitancy and geographies are aligned to the customer’s product.
Drive market success with actionable insights
Understanding the key drivers around prescribing and use will help you derive greater commercialization impact throughout your product’s lifecycle.
Understand general market highlights
The Profile Report provides detailed attributes about the therapeutic area: demographics, plan information, product utilization, prescriber specialty, and funding types.
Track product launch and market share
The Trend Report provides product performance across 30+ metrics and 23 filters, including by pharmacy channel, formulary tier and prior authorization.
Understand provider switching patterns and prescribing behavior
The Switch and Rank Switch Reports provide NPI-level detail about product and patient switches across 14 filters and 30+ metrics.
Analyze patient access to therapy and potential barriers
The Pattern and Copay Report provides information about patient adherence and discontinuation over time. Copay provides payment metrics across 17 filters including formulary tier and prior authorization.
Queries over 28 million lives of medical and pharmacy claims data
Medical claims data
Very limited access to large, eligibility-controlled medical claims data available in the market.
Longitudinal claims data
Claims data often incomplete and missing key historical data when reviewing the patient journey across multiple years.
Distilled therapeutic area data
Claims data can be difficult to set up or only directional at best, as it comes from multiple datasets and can include claims for multiple medical conditions.
Related healthcare insights
Article
Small and emerging biopharma companies are already having an impact on the industry. Learn how RWD can enhance the ability to innovate.
Article
The life sciences industry needs robust real-world data. For that data to reflect real-world populations, you need race and ethnicity data.
Article
Discover how using real-world evidence (RWE) in the life sciences industry can help catapult learning and drive impact for your company.